Consolidated Statements of Changes In Stockholders' Equity - USD ($)	Series H Preferred Stock [Member] Preferred Stock [Member]	Series H-3 Preferred Stock [Member] Preferred Stock [Member]	Series H-6 Preferred Stock [Member] Preferred Stock [Member]	Series Seed Preferred Stock [Member] Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance , value at Dec. 31, 2019				$ 9,025,245	$ 395	$ 5,001,947	$ (13,958,644)	$ 68,943
Beginning balance, shares at Dec. 31, 2019				7,360,985	3,948,078
Conversion of AYRO Preferred Stock to common stock				$ (9,025,245)	$ 201	9,025,044
Conversion of AYRO Preferred Stock to common stock, shares				(7,360,985)	2,007,193
Issuance of Series H Preferred Stock in connection with the 2020 Merger
Issuance of Series H Preferred Stock in connection with the 2020 Merger, shares	8
Issuance of Series H-3 Preferred Stock in connection with the 2020 Merger
Issuance of Series H-3 Preferred Stock in connection with the 2020 Merger, shares		2,189
Issuance of Series H-6 Preferred Stock in connection with the 2020 Merger
Issuance of Series H-6 Preferred Stock in connection with the 2020 Merger, shares			7,883
Conversion of Series H-6 Preferred Stock					$ 23	(23)
Conversion of series H6 preferred stock, shares			(7,833)		225,590
Issuance of Common Stock in connection with the 2020 Merger, net of fees					$ 495	4,451,235		4,451,730
Issuance of Common Stock in connection with the 2020 Merger net of fees, shares					4,948,377
Exchange of debt for common stock in connection with the 2020 Merger					$ 103	999,897		1,000,000
Exchange of debt for common stock in connection with the 2020 Merger, shares					1,030,585
Issuance of common stock in connection with debt offering					$ 56	461,957		462,013
Issuance of common stock in connection with debt offering, shares					553,330
Sale of common stock, net of fees					$ 928	38,409,253		38,410,181
Sale of common stock, net of fees, shares					9,278,059
Conversion of Series H-3 Preferred Stock
Issuance of Series H-3 Preferred Stock in connection with the 2020 Merger, shares		(955)			795
Exercise of warrants, net of fees					$ 507	3,926,311		3,926,818
Exercise of warrants, net of fees, shares					5,074,645
Exercise of stock options						16,669		16,669
Exercise of stock options, shares					6,817
Stock based compensation						1,736,791		1,736,791
Vested Restricted Stock					$ 1	47,916		47,917
Vested Restricted Stock, shares					15,115
Deemed divided on modification of H-5 warrants						432,727	(432,727)
Net Loss							(10,763,446)	(10,763,446)
Ending balance, value at Dec. 31, 2020					$ 2,709	64,509,724	(25,154,817)	39,357,616
Ending balance, shares at Dec. 31, 2020	8	1,234	50		27,088,584
Sale of common stock, net of fees					$ 804	58,269,025		58,269,829
Sale of common stock, net of fees, shares					8,035,835
Exercise of warrants, net of fees					$ 1	99,999		100,000
Exercise of warrants, net of fees, shares					13,642
Exercise of stock options					$ 55	1,506,944		1,506,999
Exercise of stock options, shares					555,004
Stock based compensation						7,226,902		7,226,902
Vested Restricted Stock					$ 116	(116)
Vested Restricted Stock, shares					1,158,891
Net Loss							(33,079,414)	(33,079,414)
Issuance of common stock for services					$ 2	42,298		42,300
Issuance of common stock for services, shares					15,000
Ending balance, value at Dec. 31, 2021					$ 3,687	$ 131,654,776	$ (58,234,231)	$ 73,424,232
Ending balance, shares at Dec. 31, 2021	8	1,234	50		36,866,956